Contact:
Simon Castellanos
877.443.4006
Dallas, Texas – AIS Healthcare, a leading provider of targeted drug delivery (TDD) and infusion care solutions, is proud to recognize the first week of February as National Patient Recognition Week. Since its founding in 2008, AIS Healthcare has provided comprehensive care services to patients across the country, going beyond state and industry standards to produce patient-specific prescriptions of the highest quality. Patients deserve the highest quality care possible and through exceptional TDD and infusion care services, AIS Healthcare is committed to advancing and improving the quality of life for all patients.
National Patient Recognition Week was established by the American Medical Association in 1995 and is an opportunity for healthcare professionals to reaffirm their commitment to a patient-first healthcare approach. Throughout the year, AIS Healthcare ships more than 145,000 prescriptions nationwide for patients managing chronic pain and other complex conditions. In addition to the company’s pharmacy services, AIS’ skilled nursing staff provides patient-specific care across the country from in-home immunoglobulin therapy to TDD pump refill and maintenance.
“When patients are served by AIS Healthcare, they can always expect us to put their safety, comfort, and well-being first,” said AIS Healthcare CEO Simon Castellanos. “We are grateful for the trust our patients put in us each and every day and are committed to helping all patients achieve the best possible health outcomes and quality of life.”
AIS Healthcare’s two state-of-the-art 503A compounding pharmacies exceed industry safety standards, and patient-specific prescriptions achieve unparalleled sterility. Advanced Infusion Care (AIC), a division of AIS Healthcare, operates a total of five pharmacies, dispensing essential medications and personalized care to patients across the United States with complex medical conditions like immune deficiency diseases.
AIS Healthcare carries dual accreditation from URAC and the Accreditation Commission for Health Care (ACHC), setting it apart as an industry leader in targeted drug delivery and infusion care. During this National Patient Recognition Week and beyond, AIS Healthcare will remain committed to a patient-first, empathetic approach to healthcare and changing patient lives for the better.
Advancing quality. Improving lives.
As the leading provider of targeted drug delivery and infusion care solutions, AIS Healthcare is committed to doing more of what matters. From pharmacies that put patient safety first to comprehensive services that enhance the entire care experience, we go beyond the expected in everything we do.
Learn more at aiscaregroup.com
Contact:
Simon Castellanos
877.443.4006
Dallas, Texas – AIS Healthcare, the leading provider of targeted drug delivery (TDD) and infusion care solutions, is proud to recognize January 12th as National Pharmacist Day. On this day and throughout the year, AIS Healthcare recognizes and honors the critical role pharmacists play in the continuum of patient care.
At AIS Healthcare, pharmacists go beyond what’s expected to deliver medications of the highest quality and sterility, earning recognition from the top independent pharmacy accreditors, URAC and the Accreditation Commission for Health Care (ACHC). Through a double-blind order verification process, AIS Healthcare’s TDD pharmacy technicians and pharmacists work together to ensure that medications are compounded appropriately. They also educate patients about their medications and collaborate with physicians to enhance the quality-of-care patients receive.
In recent years, the role of pharmacists has expanded, becoming an integral part of the health care system and playing an important role in patient care and recovery. Their service on behalf of patients across the country deserves to be celebrated.
“I am proud of the work of our pharmacy team and pharmacists across the country, who consistently go above and beyond to deliver safe and effective healthcare solutions to patients and their families. Their dedication and diligence are the lifeblood of our work and a key pillar of our healthcare system”, said Simon Castellanos, AIS Healthcare CEO. “Our organization is committed to continue making all the investments necessary to deliver medications of the highest possible quality for the patients and providers we serve.”
AIS Healthcare TDD operates two state-of-the-art 503A compounding pharmacies in Dallas, Texas, and Ridgeland, Mississippi, where pharmacists use a proven, proprietary process that combines aseptic processing with terminal sterilization on patient-specific formulary prescriptions to achieve unprecedented sterility assurance and extended Beyond-Use Dates (BUD). Our workspaces exceed industry standards and utilize several methods that guarantee the safety of the systems we use and the medications we produce for our patients.
Advanced Infusion Care (AIC), a division of AIS Healthcare, operates a total of five pharmacies, dispensing essential medications and personalized care to patients across the United States with complex medical conditions like immune deficiency diseases.
AIC supports patients by making medications more accessible to those in need of infusion care solutions, delivering 24/7 access to a dedicated team of clinical and support staff. Clinical pharmacists work directly with patients to address their care and provide professional assistance in the selection of Ig products that meet their unique needs.
AIS Healthcare is proud to celebrate National Pharmacist Day and acknowledges the vital
contributions of pharmacists in helping patients live healthy and full lives. For more information about AIS pharmacies, visit here.
Advancing quality. Improving lives.
As the leading provider of targeted drug delivery and infusion care solutions, AIS Healthcare is committed to doing more of what matters. From pharmacies that put patient safety first to comprehensive services that enhance the entire care experience, we go beyond the expected in everything we do.
Learn more at aiscaregroup.com
Dallas, Texas – As 2023 draws to a close, AIS Healthcare, a leading provider of targeted drug delivery (TDD) and infusion care solutions, is proud to announce that it reached the milestone of dispensing one million prescriptions to patients living with chronic pain and other complex health conditions earlier this year. Since its inception more than 10 years ago, AIS Healthcare has been putting quality and safety first in the preparation and delivery of patient-specific prescriptions across the country.
At AIS Healthcare’s two 503A specialty compounding pharmacies, best-in-class licensed pharmacists go beyond state and industry standards to produce medications of the highest quality and sterility. Both facilities invest significant resources in people and processes to be able to produce prescriptions that exceed standards and expectations, using a proven, proprietary process that combines aseptic processing with terminal sterilization—a pharmaceutical industry standard—for patient-specific formulary prescriptions to achieve unprecedented sterility assurance and extended Beyond-Use Date (BUD). This gives providers confidence in the medications they prescribe and helps to reduce medication waste.
“AIS is proud to administer life-changing medications across the United States that improve patients’ quality of life. The achievement of dispensing one million prescriptions is a significant milestone. We remain committed to prioritizing patient safety in every aspect—from person to process to protocol. Our dedication to maintaining the highest standards of quality in healthcare is unwavering. We look forward to continuing the work of advancing quality and enabling patients to live better lives,” said Simon Castellanos, AIS Healthcare CEO.
Advancing quality. Improving lives.
As the leading provider of targeted drug delivery and infusion care solutions, AIS Healthcare is committed to doing more of what matters. From pharmacies that put patient safety first to comprehensive services that enhance the entire care experience, we go beyond the expected in everything we do.
Learn more at aiscaregroup.com
Contact:
Simon Castellanos
877.443.4006
Dallas, Texas – AIS Healthcare, a leading provider of targeted drug delivery (TDD) and infusion care solutions, is proud to announce that it is has been awarded accreditations for Specialty Pharmacy, Infusion Pharmacy, and Infusion Nursing by the Accreditation Commission for Health Care (ACHC), an internationally recognized accrediting body, further setting it apart from other infusion services providers. This accomplishment underscores the company’s commitment to going beyond what’s expected to advance quality care and improve the lives of patients.
Formed in 1986, the Accreditation Commission for Health Care grants accreditation for providers in the home care and home infusion therapy industries. The Commission plays a critical role in ensuring providers deliver quality and effective services to patients. Accreditation also helps providers like AIS Healthcare to demonstrate their ability to meet official regulatory requirements and standards, resulting in a higher level of performance and a greater focus on patient care.
“This accomplishment is a testament to our employees who commit themselves to providing the highest quality care to our patients. We will continue to take the steps necessary to ensure every one of our employees, every process, and every protocol puts patient safety first. Thank you to ACHC for this important recognition and to the entire team at AIS Healthcare for their dedication to the patients we serve,” said Simon Castellanos, AIS Healthcare CEO.
Advancing quality. Improving lives.
As the leading provider of targeted drug delivery and infusion care solutions, AIS Healthcare is committed to doing more of what matters. From pharmacies that put patient safety first to comprehensive services that enhance the entire care experience, we go beyond the expected in everything we do.
Learn more at aiscaregroup.com
Contact:
Simon Castellanos
877.443.4006
Dallas, Texas – AIS Healthcare, the leading provider of targeted drug delivery and infusion care solutions, is proud to recognize December 5th as International Volunteer Day. Established in 1983, the special day is meant to acknowledge the spirit of volunteerism and giving back to one’s community at the local, national, and international level. Since its founding in 2008, AIS Healthcare has championed a workplace culture that values the unique and impactful contributions of its employees in the communities where they live and work.
AIS Healthcare is committed to supporting the many communities in which we do business and serve patients. To further this commitment, AIS Healthcare recently introduced a Volunteer Time Off paid leave benefit to allow team members to serve their communities and the charities of their choosing. This past year, our employees volunteered at the North Texas Food Bank, Ronald McDonald House Charities, Keep Jackson Beautiful, and Habitat for Humanity to name a few.
AIS Healthcare also instituted an Inclusion Council in 2021, a cross-departmental group of leaders dedicated to promoting diversity and inclusion within the company. Since its inception, the Inclusion Council has created a calendar with a theme that highlights the diversity of our organization. This year’s theme focuses on volunteerism, highlighting the company’s commitment to making a difference in our home communities.
“AIS prides itself on going beyond what’s expected to deliver the highest quality services to our patients. This includes an obligation to serve our communities and fellow neighbors. I am immensely proud of the time and energy our team devotes to the communities they call home,” said Simon Castellanos, AIS Healthcare CEO.
AIS Healthcare encourages employees with a passion for a cause or ideas on community service to share them with the Inclusion Council. The company celebrates the great service of its employees and encourages them to continue having a positive impact on the communities in which they live and work.
Advancing quality. Improving lives.
As the leading provider of targeted drug delivery and infusion care solutions, AIS Healthcare is committed to doing more of what matters. From pharmacies that put patient safety first to comprehensive services that enhance the entire care experience, we go beyond the expected in everything we do.
Learn more at aiscaregroup.com
Contact:
Simon Castellanos
877.443.4006
Dallas, Texas – AIS Healthcare, a leading provider of targeted drug delivery (TDD) and infusion care solutions, is proud to recognize National Pharmacy Week, an annual observance that takes place from October 15th – October 21st and first began in 1925. The week spotlights the critical role of pharmacists and pharmacy technicians across the healthcare industry and their contributions in advancing high-quality patient care.
“The dedication and commitment of our pharmacy teams are at the core of our mission to improve patient lives by ensuring that every person, every process, and every protocol puts patient safety first. During National Pharmacy Week, we recognize and celebrate our team’s unwavering commitment to patient care and their vital role in ensuring all our patients receive safe and effective medications,” said Simon Castellanos, CEO of AIS Healthcare.
AIS Healthcare operates two “state-of-the-art” 503A compounding pharmacies in Dallas, Texas, and Ridgeland, Mississippi where pharmacists use a proven, proprietary process that combines aseptic processing with terminal sterilization—a pharmaceutical industry standard—on patient-specific formulary prescriptions to achieve unprecedented sterility assurance and extended Beyond-Use Dates (BUD).
Pharmacists play an important role in improving patient outcomes by ensuring that medications are compounded and used appropriately, educating patients about their medications, and collaborating with physicians to enhance the quality of care for our patients. Our pharmacy teams are critical in achieving dual accreditation by URAC and the Accreditation Commission for Health Care (ACHC), further setting AIS Healthcare apart from other compounding pharmacies and infusion services providers.
AIS Healthcare is proud to celebrate National Pharmacy Week and acknowledges the vital contributions of pharmacists and pharmacy technicians in delivering safe, effective, and innovative healthcare solutions to patients across the nation. For more information about National Pharmacy Week and the American Society of Health-System Pharmacists, please visit here.
As the leading provider of targeted drug delivery and infusion care solutions, AIS Healthcare is committed to doing more of what matters. From pharmacies that put patient safety first to comprehensive services that enhance the entire care experience, we go beyond the expected in everything we do.
Learn more at aiscaregroup.com
CONTACT:
Jud Hall
877.443.4006
Infusion care provider highlights importance of safe and cost-effective options for immunoglobulin treatment
Dallas, TX – Advanced Infusion Care (AIC), a division of AIS Healthcare, today announced its participation in the Immunoglobulin National Society (IgNS) 12th National Conference, which takes place on October 5th – 8th in Denver, Colorado. The annual conference provides a forum for industry leaders across multiple disciplines to explore major therapy updates, clinical management, standards of practice, and expert workshops.
By providing a team-based approach to intravenous immunoglobulin (IVIG) therapy, AIC delivers specialized treatment options to individuals living with immunodeficiencies and other complex conditions. For these patients, IVIG is used to manage various immunodeficiency states and other conditions, including autoimmune, infectious, and other inflammatory ailments. The ultimate goal of this therapy is to normalize a compromised immune system, fight infections, and have patients receive care in the comfort of their own homes.
This year at IgNS, AIC representatives will present their analysis of policy changes to reduce the overall infusion escalation time for patients with a 10% intravenous immunoglobulin product.
“At AIC, we are constantly innovating to ensure that our infusion care services best meet the needs of our patients. The Immunoglobulin National Society’s annual conference is an important venue for AIC and other leaders to come together to advance our industry, share best practices, and deliver the best possible care for patients,” said Jud Hall, President at AIC.
The specialty pharmacy provider traditionally follows a policy of increasing IVIG infusion rates every 30 minutes. To accommodate patient preferences and changing healthcare reimbursement practices, AIC reevaluated this infusion policy to explore the possibility of reducing the overall infusion time per patient and identify more cost-effective and safe options for IVIG administration.
AIC’s retrospective review of some patient records over a six-month period showed that 11 of the 13 observed patients reported no adverse experiences with two patients reporting adverse experiences across 70 infusions (2.9% incidence). Patients also reported satisfaction with the new shorter infusion rate of 15 minutes for 68 out of the 70 infusions. The analysis also saw a mean reduction of 41.7 minutes (23.9% per visit) in IVIG infusion time with the transition to the 15-minute escalation protocol leading to a reduction in the per visit cost of nursing services.
On Saturday, October 7th, AIC will present their findings to IgNS attendees during a poster board session, where experts will demonstrate how a reduction in infusion time could positively impact nursing costs, patient quality of life, and infusion-related adverse event occurrence. AIC’s analysis indicates the change in policy resulted in well-tolerated and shorter infusion times which may have a positive impact on patient quality of life and healthcare resource utilization.
AIC is dually accredited by URAC and the Accreditation Commission for Health Care (ACHC), further distinguishing itself as an infusion services provider. AIC is also a member of IgNS and is regularly inspected by national and state boards of pharmacy.
In recent months, AIC announced the grand reopening of a newly designed pharmacy in Valdosta, Georgia. AIC also made medications like GAMMAKED™ and LEQEMBI™ available to patients through its locations in Valdosta, Georgia; Birmingham, Alabama; Clinton, Mississippi; Panama City, Florida; and Dallas, Texas.
Physicians interested in AIC care services should contact their AIC representatives to get started or visit us at www.aiscaregroup.com/our-divisions/infusion-care/.
Advancing quality. Improving lives.
As the leading provider of targeted drug delivery and infusion care solutions, AIS Healthcare is committed to doing more of what matters. From pharmacies that put patient safety first to comprehensive services that enhance the entire care experience, we go beyond the expected in everything we do.
Learn more at aiscaregroup.com
Contact:
Simon Castellanos
877.443.4006
Dallas, Texas – AIS Healthcare, a leading provider of targeted drug delivery (TDD) and infusion care solutions, announced its participation in the National Association of Specialty Pharmacy (NASP) 2023 Annual Meeting and Expo, which took place on September 18th – 21st in Grapevine, Texas. At the NASP 2023 Annual Meeting and Expo, AIS Healthcare sponsored a continuing education symposium through an unrestricted educational grant that focused on the critical topic of USP 797 guideline revisions, a set of standards developed by U.S. Pharmacopeia (USP) governing the safe compounding of sterile preparations in healthcare settings, and its impact on the healthcare industry. These topics were discussed during panel discussions with industry experts and led by Katrina K. Harper, Director of Clinical Education, AIS Healthcare.
AIS Healthcare’s symposium, The 411 Before 911 on USP 797: Changes, Challenges, and Choices, featured speakers including:
AIS Healthcare is dedicated to advancing best practices across the specialty pharmacy industry. The NASP Annual Meeting and Expo served as a crucial platform for industry leaders to come together to promote the highest standards of sterility, quality, and safety in the development of compounded medications.
“Advancing quality and improving lives is at the center of what this event is about. The NASP 2023 Annual Meeting and Expo provided an important setting for experts within our industry to engage and learn from one another with the goal of best serving our patients’ unique needs. We were proud to facilitate important discussions about how we prioritize sterility, quality, and safety in all the medications we produce for patients,” said Simon Castellanos, CEO of AIS Healthcare.
USP 797 revisions become official and enforceable on November 1, 2023. Pharmacies preparing Category 3 compounded sterile preparations (CSPs), formerly known as high-risk preparations, now face more rigorous standards. These revisions will require increased staffing, training, and investment, all of which may pose challenges for pharmacies. AIS Healthcare is already meeting or exceeding these revised standards.
AIS Healthcare is honored to have participated in the NASP 2023 Annual Meeting and Expo and is committed to fostering innovation and excellence in pharmaceutical compounding. For more information about the NASP 2023 Annual Meeting and Expo, please visit www.naspmeeting.com.
Advancing quality. Improving lives.
As the leading provider of targeted drug delivery and infusion care solutions, AIS Healthcare is committed to doing more of what matters. From pharmacies that put patient safety first to comprehensive services that enhance the entire care experience, we go beyond the expected in everything we do.
Learn more at aiscaregroup.com
Contact:
Simon Castellanos
877.443.4006
Dallas, Texas – AIS Healthcare, a leading provider of targeted drug delivery (TDD) and infusion care solutions, is proud to recognize September 17th as World Patient Safety Day. Throughout its TDD and infusion care divisions, AIS Healthcare is committed to advancing quality and improving the lives of patients with a focus on safety and well-being.
Established in 2019 by the World Health Organization (WHO), World Patient Safety Day brings together patients, families, caregivers, nurses, and healthcare leaders to show their commitment to patient safety. AIS Healthcare reaffirms its pledge to continue exceeding industry standards to produce medications of the highest quality and sterility for individuals living with complex medical conditions. For in-home immunoglobulin therapy infusion and intrathecal pump medication delivery and maintenance, AIS Healthcare’s highly skilled nursing and pharmacy teams provide specialized care that leads to better patient outcomes.
World Patient Safety Day calls attention to the supreme importance of patient safety. “We believe that true progress in healthcare begins with patient safety as its foundation,” said Simon Castellanos, Chief Executive Officer of AIS Healthcare. “Our commitment to enhancing patient well-being through innovative solutions is unwavering. At AIS Healthcare, we strive to raise the bar across our industry to ensure patients have absolute trust in the safety and quality of their medications and services.”
Across its TDD division, AIS Healthcare ships more than 140,000 patient-specific prescriptions annually to all 50 states for patients managing chronic pain and complex medical conditions. Throughout its operations, AIS Healthcare goes beyond industry and state-level standards to produce medications of the highest safety and quality.
AIS Healthcare carries dual accreditation from URAC and the Accreditation Commission for Health Care (ACHC), distinguishing itself as an industry leader in targeted drug delivery and infusion care. In observance of World Patient Safety Day, AIS Healthcare remains dedicated to delivering transformative services across the care continuum, consistently prioritizing patient safety and well-being.
Advancing quality. Improving lives.
As the leading provider of targeted drug delivery and infusion care solutions, AIS Healthcare is committed to doing more of what matters. From pharmacies that put patient safety first to comprehensive services that enhance the entire care experience, we go beyond the expected in everything we do.
Learn more at aiscaregroup.com
CONTACT:
Simon Castellanos
877.443.4006
AIS Healthcare reaffirms commitment to improving the lives of patients living with chronic pain
Dallas, TX – AIS Healthcare, the leading provider of targeted drug delivery (TDD) and infusion care solutions, is proud to recognize September as Pain Awareness Month. Throughout this month, AIS Healthcare aims to raise awareness about the challenges faced by individuals living with chronic pain and highlight the importance of accessible and effective pain management solutions. In the United States, chronic pain is a widespread issue affecting more than 51 million Americans. AIS Healthcare serves some of the most vulnerable chronic pain patients through TDD, offering patients customized medications from our state-of-the-art pharmacies and care from highly trained nursing staff across the country.
Our cutting-edge treatment empowers patients to manage their pain effectively and lead full and active lives. As a leading provider in the pain management field, AIS Healthcare goes beyond traditional methods, offering innovative and compassionate solutions that aim to bring relief to those who need it most. During Pain Awareness Month and beyond, AIS Healthcare is committed to raising standards of care, quality, and safety across the industry to positively impact our patients’ quality of life.
“We pride ourselves on supporting patients to live with less pain, enabling them to be fully present and active with their families and in their communities. Our state-of-the-art quality and safety standards are critical to alleviating the burden of pain for our patients and restoring hope for those managing chronic conditions,” said Simon Castellanos, Chief Executive Officer of AIS Healthcare. “Our approach goes beyond merely addressing the physical aspects of pain; we recognize the emotional toll it takes on individuals and their families.By consistently raising the bar for excellence in targeted drug delivery and infusion care, we can truly transform our patients’ lives by dramatically improving their quality of life.”
Since being established in 2008, AIS Healthcare has been delivering care that puts patients first. At every step of a patient’s care, AIS Healthcare aims to be a supportive partner by delivering customized medications and personalized services while ensuring the patient’s emotional and psychological well-being are cared for as well.
AIS Healthcare is dually accredited by URAC and the Accreditation Commission for Health Care (ACHC), further setting it apart from other compounding pharmacies and infusion services providers. AIS Healthcare continues to deliver transformative services across the care continuum for its patients.
About AIS Healthcare
Advancing quality. Improving lives.
As the leading provider of targeted drug delivery and infusion care solutions, AIS Healthcare is committed to doing more of what matters. From pharmacies that put patient safety first to comprehensive services that enhance the entire care experience, we go beyond the expected in everything we do.
Learn more at aiscaregroup.com.